3 research outputs found

    The psychological rejection in kidney and liver transplants

    No full text
    Organ transplantation is an effective therapy to improve the quality of life (QoL) in chronic patients. It is still high the imbalance between the number of the patients in the waiting list and the number of available organs. It causes a long permanence in the waiting lists. For many patients, the organ transplantation is the only way to have a sufficient improvement of the quality of life and sometimes it is the only way to survive. The study of the patient’s personality thus is an important factor in order to avoid that the transplant could cause mental illness. Pre-transplantation relational, cognitive, emotional assessment can help to plan a rehabilitation in order to improve the therapy outcome. Aim of this pilot study is to investigate the possible predicting role of the psychological state (anxiety, introversion-extroversion, psychoticism, antisocial, psychophysiological disorders, fears, depression, obsessions and compulsions) in the organ graft

    Severe asthma: One disease and multiple definitions

    Get PDF
    Introduction There is, so far, no universal definition of severe asthma. This definition usually relies on: number of exacerbations, inhaled therapy, need for oral corticosteroids, and respiratory function. The use of such parameters varies in the different definitions used. Thus, according to the parameters chosen, each patient may result in having severe asthma or not. The aim of this study was to evaluate how the choice of a specific definition of severe asthma can change the allocation of patients. Methods Data collected from the Severe Asthma Network Italy (SANI) registry were analyzed. All the patients included were then reclassified according to the definitions of U-BIOPRED, NICE, WHO, ATS/ERS, GINA, ENFUMOSA, and TENOR. Results 540 patients, were extracted from the SANI database. We observed that 462 (86%) met the ATS/ERS criteria as well as the GINA criteria, 259 (48%) the U-Biopred, 222 (41%) the NICE, 125 (23%) the WHO, 313 (58%) the Enfumosa, and 251 (46%) the TENOR criteria. The mean eosinophil value were similar in the ATS/ERS, U-Biopred, and Enfumosa (528, 532 and 516 cells/mcl), higher in WHO and Tenor (567 and 570 cells/mcl) and much higher in the NICE classification (624 cells/mcl). Lung function tests resulted similarly in all groups, with WHO (67%) and ATS/ERS-GINA (73%), respectively, showing the lower and upper mean FEV1 values. Conclusions The present observations clearly evidence the heterogeneity in the distribution of patients when different definitions of severe asthma are used. However, the recent definition of severe asthma, provided by the GINA document, is similar to that indicated in 2014 by ATS/ERS, allowing mirror reclassification of the patients examined. This lack of homogeneity could complicate the access to biological therapies. The definition provided by the GINA document, which reflects what suggested by ATS/ERS, could partially overcome the problem

    Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

    No full text
    corecore